# EDGAR Filing Document

**Accession Number:** 0002018462
**File Stem:** 0001493152-25-027574
**Filing Date:** 2025-12
**Character Count:** 9943
**Document Hash:** a8006130ac8668b4b369e97ecd0222c3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-027574.hdr.sgml**: 20251212

**ACCESSION NUMBER**: 0001493152-25-027574

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251212

**FILED AS OF DATE**: 20251212

**DATE AS OF CHANGE**: 20251212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PicoCELA Inc.
- **CENTRAL INDEX KEY:** 0002018462
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRIC LIGHTING & WIRING EQUIPMENT [3640]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** M0
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42470
- **FILM NUMBER:** 251569191

**BUSINESS ADDRESS:**
- **STREET 1:** 2-34-5 NINGYOCHO, SANOS BUILDING,
- **STREET 2:** NIHONBASHI CHUO-KU,
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 103-0013
- **BUSINESS PHONE:** 81 03-6661-2780

**MAIL ADDRESS:**
- **STREET 1:** 2-34-5 NINGYOCHO, SANOS BUILDING,
- **STREET 2:** NIHONBASHI CHUO-KU,
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 103-0013

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of December 2025**

**Commission File Number: 001-42470**

**PicoCELA Inc.**

**2-34-5 Ningyocho, SANOS Building, Nihonbashi**

**Chuo-ku, Tokyo 103-0013 Japan**

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

**Convocation of Annual General Meeting of Shareholders of PicoCELA Inc.**

In accordance with the rules and regulations of the Japanese Companies Act, PicoCELA Inc. has caused a notice and accompanying information, including voting instructions, to be sent to all holders of its common shares and American Depositary Shares with respect to its annual general meeting to be held in Tokyo, Japan on December 29, 2025 at 10:00 a.m., Japanese Standard Time. A complete copy of the notice is attached as Exhibit 99.1.

The notice furnished in this report as Exhibit 99.1 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Notice of the Annual General Meeting of Shareholders](ex99-1.htm) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **PicoCELA Inc.** | **PicoCELA Inc.** |
| Date: December 12, 2025 | By: | */s/ Hiroshi Furukawa* |
|  | Name: | Hiroshi Furukawa |
|  | Title: | Chief Executive Officer and Representative Director |

---

## Exhibit 99.1

**Exhibit 99.1**

**Convocation Notice of the Annual General Shareholders' Meeting**

December 12, 2025

Dear Shareholders:

You are cordially invited to attend the Annual General Shareholders' Meeting of PicoCELA Inc. (the "Company") which will be held as described below.

**If you are unable to attend the meeting, we kindly ask that you indicate your approval or disapproval on the proxy form, affix your seal, and return it so that it arrives no later than 5:00 p.m. on December 28, 2025.**

---

| | | |
|:---|:---|:---|
| **1.** | **Date and time:** | Monday, December 29, 2025 at 10:00 a.m. |
| **2.** | **Location:** | Room 604, At Business Center Tokyo Station Yaesu Dori, Yaesu-Dori Hata Building, 1-9-8 Hacchobori, Chuo-ku, Tokyo (Please note that the venue changed from the previous meeting.) |
| **3.** | **Purpose of the meeting** |  |
|  | **Matters to be reported** | The business report, financial statements, and financial statement audit reports from the Accounting Auditor and the Audit and Supervisory Board for the fiscal year (from October 1, 2024 through September 30, 2025) |
|  | **Matters to be resolved** |  |

---

---

| | |
|:---|:---|
| **Proposal 1** | **Implementation of Reverse Stock Split** |
| **Proposal 2** | **Grant of Restricted Common Shares as Share-Based Compensation for Directors Who Are Not Audit and Supervisory Board Members** |

---

The outlines of above proposals are described in "Reference Documents Relating to the Solicitation of Proxy Votes".

● The record
 date for the Annual General Shareholders' Meeting is September 30, 2025.

● For
 those attending the meeting, please present the enclosed Proxy Form at the reception desk on arrival at the venue.

● Please
 note that on the date of this letter the same materials (Convocation of the Annual General Shareholders' Meeting with the Annual
 Business Report and the audited financial statements for the year ended September 30, 2025) are posted at: <u>https://picocela.com/en/news/ir/</u> 

Hiroshi Furukawa

CEO and Representative Director

PicoCELA Inc.

2-34-5 Ningyocho, Nihonbashi, Chuo-ku, Tokyo

**Proxy Form**

To PicoCELA Inc.:

I hereby appoint shareholder ______________________ as proxy holder to represent me and delegate the following authorities.

1. Attend
 the Annaul General Shareholders' Meeting of PicoCELA Inc. to be held on Monday, December
 29, 2025, and exercise the voting rights in accordance with my instructions (as indicated
 by a circle) on the following proposals.

However, if no instructions are given regarding a proposal, or if an amendment to a proposal is submitted, I hereby delegate full discretion to act on my behalf in either case.

2. Appoint
 a substitute proxy.

Proposal 1 <u>Agree</u> <u>Disagree</u> <br> <u>Proposal 2</u> <u>Agree</u> <u>Disagree</u>

December ______________, 2025

Address:

Name:________________________________________________ Seal/Sign:________________________

Number of voting rights:_______________rights

**Reference Documents Relating to the Solicitation of Proxy Votes**

---

| | | |
|:---|:---|:---|
| **1.** | **Solicitor of proxy votes** | Hiroshi Furukawa |
|  |  | CEO and Representative Director<br>|
|  |  | PicoCELA Inc. |

---

**2.** **Proposals and reference information** 

---

| | |
|:---|:---|
| **Proposal 1** | **Reverse Stock Split** |

---

In order to comply with NASDAQ listing requirements and avoid delisting, we would like to implement a reverse stock split as follows:

● Reverse stock split ratio: We are consolidating thirty (30) shares into one (1) share.

● Fractional share: In case fractional shares are produced as a result of 30 to 1 reverse stock split, based on the rules stipulated in the Japanese Companies Acts, the Company will consolidate and auction such fractional shares on behalf of the fractional shareholders, and distribute proceeds if any from the auction sale to the fractional shareholders based on the prorate share of the respective fractional shares.

● Effective Date: January 26, 2026

● On the effective date of Reverse Stock Split, the authorized number of shares is adjusted to 4,615,224 shares.

● Other matters: The detailed procedures of the reverse stock split is delegated to the Board of Directors to resolve and execute based on the above.

Proposal 2 Grant of Restricted Common Shares as Share-Based Compensation for Directors Who Are Not Audit and Supervisory Board Members

We would like to adapt a program (the "Program") to grant restricted common shares to the Directors who are not Audit and Supervisory Board members of the Company. The Company requests approval for the determination of the limit on the amount of monetary compensation claims provided for the purpose of granting eligible Directors restricted common shares separately from the basic remuneration of Directors who are not Audit and Supervisory Board members, and for the determination of the limit on the total number of restricted shares to be delivered as follows:

The Program term is for 20 years, from January 1, 2026 to December 31, 2045. Upon the introduction of this Program, the limit on the cumulative aggregate amount of the share-based compensation provided through the grant of restricted common shares shall be ¥800 million, and the limit on the total number of shares to be granted shall be 50 million shares. The amount of share-based compensation based on the Company's common shares granted through the issuance of new shares or the disposition of treasury shares under this Program is calculated by multiplying net assets per share by the number of shares granted through the issuance of new shares or the disposition of treasury shares.

We have determined that this proposal is appropriate as a program to provide recipients with incentives to contribute to the long-term and stable enhancement of the Company's corporate value. We have also determined that this is a sound management measure because, unlike the provision of cash, share-based compensation will not use any cash resources of the Company. Details of the restricted common shares and the conditions for granting are as follows:

1. Eligible
 recipients: The Company's Directors who are not Audit and Supervisory Board
 members and who have served as Directors of the Company for a consecutive period of at least
 seven (7) years as of the first grant date.

2. Transfer
 and resale restriction period: Transfer or resale is prohibited for 20 years from the date
 of the grant.

3. Grant
 method: By entering an agreement on the allocation of restricted common shares, the Company
 issues or disposes of the Company's common shares.

4. Other:
 Detailed conditions regarding restricted shares shall be determined by the resolution of
 the Board of Directors.

Total number of restricted shares is adjusted in cases of stock split and reverse stock split

END